Page last updated: 2024-08-23

flubendazole and Alveolar Echinococcosis, Hepatic

flubendazole has been researched along with Alveolar Echinococcosis, Hepatic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bardonnet, K; Blagosklonov, O; Bresson-Hadni, S; Delabrousse, E; Grenouillet, F; Mantion, GA; Miguet, JP; Vuitton, DA1
Barale, T; Capron, A; Hervé, P; Lasségue, A; Miguet, JP; Seillés, E; Vuitton, DA1
Barale, T; Estavoyer, JM; Gillet, M; Lassègue, A; Miguet, JP; Minazzi, H; Vuitton, D1
Canton, P; Dureux, JB; Gérard, A; Roche, G1
Coulaud, JP; Hay, JM; Manuel, C; Meulemans, A; Mohler, J; Saimot, AG1
Bracard, S; Claudon, P; Floquet, J; Gérard, A; Jacquier, P; Vespignani, H; Weber, M1

Reviews

1 review(s) available for flubendazole and Alveolar Echinococcosis, Hepatic

ArticleYear
[Neurological manifestations of alveolar echinococcosis].
    Revue neurologique, 1988, Volume: 144, Issue:2

    Topics: Aged; Brain Diseases; Echinococcosis, Hepatic; Echinococcosis, Pulmonary; Electroencephalography; Female; Humans; Male; Mebendazole; Middle Aged; Recurrence; Spinal Cord Compression

1988

Trials

1 trial(s) available for flubendazole and Alveolar Echinococcosis, Hepatic

ArticleYear
Humoral and cellular immunity in patients with hepatic alveolar echinococcosis. A 2 year follow-up with and without flubendazole treatment.
    Parasite immunology, 1984, Volume: 6, Issue:4

    Topics: Adult; Aged; Antibodies; Antibody Formation; Antinematodal Agents; Benzimidazoles; Clinical Trials as Topic; Complement C4; Complement System Proteins; Echinococcosis, Hepatic; Female; Follow-Up Studies; Hemagglutination Tests; Humans; Immunity, Cellular; Immunoelectrophoresis; Immunoglobulin A; Immunoglobulin G; Male; Mebendazole; Middle Aged

1984

Other Studies

4 other study(ies) available for flubendazole and Alveolar Echinococcosis, Hepatic

ArticleYear
30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient.
    Annals of clinical microbiology and antimicrobials, 2013, Jan-02, Volume: 12

    Topics: Adult; Albendazole; Antinematodal Agents; Echinococcosis; Echinococcosis, Hepatic; Follow-Up Studies; Humans; Immunosuppression Therapy; Liver Diseases; Lung; Lung Diseases; Male; Mebendazole; Positron-Emission Tomography; Treatment Outcome

2013
[Treatment of human alveolar echinococcosis with flubendazole. Clinical, morphological and immunological study].
    Gastroenterologie clinique et biologique, 1984, Volume: 8, Issue:4

    Topics: Adult; Antibodies; Benzimidazoles; Echinococcosis, Hepatic; Female; Humans; Male; Mebendazole; Middle Aged

1984
[Treatment of alveolar echinococcosis with flubendazole. Pharmacological study (author's transl)].
    Pathologie-biologie, 1982, Volume: 30, Issue:6

    Topics: Anticestodal Agents; Benzimidazoles; Echinococcosis, Hepatic; Humans; Kinetics; Liver; Mebendazole; Radioimmunoassay

1982
[Pharmacokinetic study of flubendazole in human hydatid disease caused by Echinococcus granulosus. Preliminary results (author's transl)].
    La Nouvelle presse medicale, 1981, Oct-24, Volume: 10, Issue:38

    Topics: Adult; Anticestodal Agents; Benzimidazoles; Echinococcosis; Echinococcosis, Hepatic; Female; Humans; Kinetics; Male; Mebendazole; Radioimmunoassay; Splenic Diseases

1981